ArticleCancers2022

Evaluating Cardiotoxicity in Breast Cancer Patients Treated with HER2 Inhibitors: Could a Combination of Radionuclide Ventriculography and Cardiac Biomarkers Predict the Cardiac Impact?

Mirela Gherghe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.